singlet oxygen has been researched along with pindolol in 1 studies
Studies (singlet oxygen) | Trials (singlet oxygen) | Recent Studies (post-2010) (singlet oxygen) | Studies (pindolol) | Trials (pindolol) | Recent Studies (post-2010) (pindolol) |
---|---|---|---|---|---|
3,870 | 4 | 2,322 | 3,718 | 662 | 92 |
Protein | Taxonomy | singlet oxygen (IC50) | pindolol (IC50) |
---|---|---|---|
Beta-2 adrenergic receptor | Homo sapiens (human) | 0.0005 | |
Beta-1 adrenergic receptor | Homo sapiens (human) | 0.0009 | |
Beta-3 adrenergic receptor | Homo sapiens (human) | 0.088 | |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.048 | |
5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.048 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allegretti, P; Bertolotti, SG; Criado, S; Furlong, J; García, NA; La Falce, E; Mártire, D | 1 |
1 other study(ies) available for singlet oxygen and pindolol
Article | Year |
---|---|
Singlet molecular oxygen generation and quenching by the antiglaucoma ophthalmic drugs, Timolol and Pindolol.
Topics: Adrenergic beta-Antagonists; Animals; Glaucoma; Humans; Kinetics; Light; Photolysis; Photosensitizing Agents; Pindolol; Singlet Oxygen; Timolol | 2002 |